A groundbreaking review in Biological Diversity proposes a proactive, AI - integrated approach to stop biological invasions ...

Biological invasion has become one of the most significant drivers of global ecological disruption, causing billions of dollars in ...

Long COVID, officially known as post-acute sequelae of SARS-CoV-2 infection (PASC), affects an estimated 10-20% of individuals who have contracted SARS-CoV-2. This condition can manifest with a range ...

Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies. A new study ...

Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today provided a 2026 corporate outlook and update on key ...

As part of the collaboration, Lilly and Revvity will jointly fund access for selected participants, including access to Signals One and Signals Xynthetica software offerings and modeling credits. This ...

People with type 2 diabetes are more likely to develop heart failure, but the reasons are not fully explained by cholesterol, blood pressure and blocked arteries alone. A new study adds another piece ...

Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced that Chief Executive Officer Ted Myles will ...

Understand the role of reproductive biotech in overcoming biological limits in fertility treatments and enhancing success ...

Aperture Therapeutics, a biotechnology company pioneering next-generation precision medicines for neurodegenerative diseases, today announced the advancement of its matrix metalloproteinase-9 (MMP9) ...

Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for ...

A Viewpoint published in Genomic Psychiatry by Dr. Mayana Zatz and colleagues at the Human Genome and Stem Cell Research ...